11:47 AM EST - Aeterna Zentaris Inc. : announced that the U.S. National Institutes of Health has awarded Dr. Jacek Pinski, Associate Professor of Medicine at the Norris Comprehensive Cancer Center of the University of Southern California, a grant of about $1.5 million U.S. over three years to conduct a Phase 1/2 study in refractory prostate cancer with the Company's doxorubicin LHRH receptor targeted conjugate compound, AEZS-108. Aeterna Zentaris Inc.
shares T.AEZ are trading down $0.02 at $1.19.
